Enrollment ongoing in Phase 2 KOURAGE trial of AuxoraTM in acute kidney injury (AKI) and respiratory failure; data expected around the end of 2025 ...

The following is a summary of “Tebentafusp Induces a T-Cell–Driven Rash in Melanocyte-Bearing Skin as an Adverse Event ...

Dr. Andrea Love is an immunologist and microbiologist… and founder of Immunologic, a science and health education ...

REVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) is a life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of ...

The annual meeting of the American Academy of Allergy, Asthma & Immunology was held from Feb. 28 to March 3 in San Diego, drawing clinicians, academicians, allied health professionals, and others ...

AUSTIN, Texas and HAMILTON, ON and SAN DIEGO, March 12, 2025 /PRNewswire/ -- Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell ...

Allogeneic hematopoietic stem-cell transplantation (HSCT) remains one of the only curative therapies for acute leukemias, ...

We evaluate the clinical, microbiologic, and immunologic effects of probiotics in acute infectious diarrhea. Conclusions: This probiotics mixture reduced the severity of diarrhea and length of ...